BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 25, 2002
View Archived Issues
KS Biomedix, Nycomed Sign Deal For TransMID 107 Cancer Therapy
LONDON - KS Biomedix Holdings plc agreed to a licensing deal worth up to US$60 million for its TransMID 107 brain cancer treatment with Nycomed Group. (BioWorld International)
Read More
Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders
Read More
BCLC Says BRCA1 Increases Risk Of Other Cancers In Women
Read More
Modex, IsoTis Plan To Merge Programs In Orthopedics, Skin
Read More
EU Urges Use Of Biotechnology In And From Developing World
Read More
European Parliament Aims To Tighten GM Trade Rules
Read More
Eirx Pharma Formed Through Three-Way Anglo-Irish Merger
Read More
Cardion Closes EUR10M Financing To Fund CRB-15, Stem Cell Work
Read More
Acambis Completes Manufacture Of First Batch Of Smallpox Vaccine
Read More
Zentaris, Access Oncology Enter $30M Alliance For Cancer Drug
Read More
Other News To Note
Read More
Genset Shareholders Accept Bid From Serono; Integration Begins
Read More